Atlas Funding 2026-1 - NOTICE OF CLERICAL ERROR IN PROSPECTUS

Experian

23/04/2026 15:26

RNS Number : 7164B

Atlas Funding 2026-1 PLC

23 April 2026

 

ATLAS FUNDING 2026-1 PLC

23 April 2026

 

RNS ANNOUNCEMENT - NOTICE OF CLERICAL ERROR IN PROSPECTUS

 

Atlas Funding 2026-1 PLC (the "Issuer") hereby confirms that the prospectus in respect of Atlas Funding 2026-1 PLC (the "Prospectus"), which was approved by the Financial Conduct Authority on 21 April 2026, contains the following clerical errors relating to the accounting reference date of the Issuer and Atlas Holdings 2026-1 Limited ("Holdings").

 

In the Prospectus, the accounting reference date of the Issuer is incorrectly stated as 31 March and the first statutory accounts of the Issuer will be drawn up to 31 March 2027. The correct accounting reference date of the Issuer should instead be 31 December and the first statutory accounts of the Issuer will instead be drawn up to 31 December 2026.

 

In the Prospectus, the accounting reference date of Holdings is incorrectly stated as 31 March and the first statutory accounts of Holdings will be drawn up to 31 March 2027. The correct accounting reference date of Holdings should instead be 31 December and the first statutory accounts of Holdings will instead be drawn up to 31 December 2026.

 

For further information, please contact:

Atlas Funding 2026-1 PLC
For the attention of: The Directors
10th Floor, 5 Churchill Place
London, United Kingdom,
E14 5HU
Telephone: +44 (0) 203 855 0285
Email:atlas2026-1-uk@cscglobal.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
STRPPUQACUPQGWW